"In the Spotlight: LinXis technology discussed in Dutch medical oncology journal"Read more
LinXis rolls out two product pipelines, aiming at large, global, and unmet needs.
We are focusing our product pipeline on two distinct indications: breast cancer and chronic liver disease. While these two indications may seem a world apart, both represent large global medical needs. More importantly, excellent targets have been identified in both areas of disease, opening up the possibility to leverage our technology to its full potential.